XML 49 R38.htm IDEA: XBRL DOCUMENT v3.24.3
Stock Incentive Plans (Tables)
9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation
Stock-based compensation expense by classification included within the consolidated statements of operations and comprehensive income (loss), including $1.5 million recognized as stock-based compensation expense upon the achievement of a technical milestone by Ginkgo Bioworks Holdings, Inc., or Ginkgo, during the nine months ended September 30, 2023 as described in Note 15, was as follows (in thousands):
 Three Months Ended
September 30,
Nine Months Ended
September 30,
 2024202320242023
Research and development$799 $1,189 $2,287 $5,058 
General and administrative896 1,132 2,430 3,322 
Total stock-based compensation expense$1,695 $2,321 $4,717 $8,380 
Schedule of Weighted Average Assumptions Used
The estimated grant date fair values of stock option awards granted under the 2016 Plan and the 2018 Inducement Incentive Award Plan were calculated using the Black-Scholes option pricing model based on the weighted-average assumptions in the following table. No stock options were granted during the three months ended September 30, 2023.
Three Months Ended
September 30,
Nine Months Ended
September 30,
 202420242023
Risk-free interest rate4.05 %4.04 %3.95 %
Dividend yield— — — 
Expected term (in years)6.236.205.94
Expected volatility94.98 %95.07 %94.64 %
Weighted-average fair value of common stock$17.97 $19.79 $34.50 
Schedule of Options Activity
The following table summarizes the stock option activity under the 2016 Plan, the 2018 Inducement Incentive Award Plan, and Old Cartesian Plan for options for common stock:
   Weighted-average 
 Number ofremainingAggregate
 common stockWeighted-averagecontractual termintrinsic value
 optionsexercise price ($)(in years)(in thousands)
Outstanding at December 31, 2023776,865 $2.97 6.50$13,760 
Granted908,675 $19.79   
Converted from options for Series A Preferred Stock470,403 $2.40 
Exercised(106,073)$3.12   
Forfeited(77,681)$17.12   
Outstanding at September 30, 20241,972,189 $10.02 7.11$15,207 
Vested at September 30, 2024976,876 $2.84 5.09$13,020 
Vested and expected to vest at September 30, 20241,830,212 $9.26 6.94$15,190 
The following table summarizes the stock option activity under the Old Cartesian Plan for options for Series A Preferred Stock:
 Number of Weighted-average 
 Series A remainingAggregate
 Preferred StockWeighted-averagecontractual termintrinsic value
 optionsexercise price ($)(in years)(in thousands)
Outstanding at December 31, 202314,112.299 $79.94 5.91$8,601 
Converted to options for common stock(14,112.299)$79.94   
Outstanding at September 30, 2024
— $— 
Schedule of Disclosure of Share-based Compensation Arrangements by Share-based Payment Award
The following table summarizes the Company’s restricted stock units under the 2016 Plan, the 2018 Inducement Incentive Award Plan, and the Old Cartesian Plan:
 Number of sharesWeighted-average
grant date
fair value ($)
Unvested at December 31, 2023
— $— 
Granted477,037 19.86 
Forfeited(28,826)19.80 
Unvested at September 30, 2024
448,211 $19.86